Recombinant Human Insulin-like Growth Factor-Binding Protein 7
RP01585
Product Specifications
| Product Type | Recombinant protein |
|---|---|
| Applications | Bioactivity, Endotoxin |
| Source | E. coli. |
| UniProt No. | Q16270 |
| Purity | > 95 % by SDS-PAGE and HPLC analyses. |
| Bioactivity | Testing in Progress. |
| Endotoxin | Less than 0.1 EU/μg of rHuIGF-BP7 as determined by LAL method. |
| Molecular Weight | Approximately 26.4 kDa, a single non-glycosylated polypeptide chain containing 256 amino acids. |
| Formulation | Lyophilized from a 0.2 μm filtered concentrated solution in 20 mM Tris-HCl, pH 8.6, 150 mM NaCl. |
| Alternative Names | IGF-BP7, AGM; PSF; TAF; FSTL2; IBP-7; MAC25; IGFBP-7; RAMSVPS; IGFBP-7v; IGFBPRP1, IGFBP7, Human |
| Storage | -20C |
| Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
| Research Area | Signal Transduction |